Related Experiment Video
Updated: Jul 10, 2025

10:39
Localizing Function-specific Targets for Transcranial Magnetic Stimulation in the Absence of Navigation Equipment
Published on: May 23, 2025
592
Targeting Symptom-Specific Networks With Transcranial Magnetic Stimulation
Shan H Siddiqi1, Michael D Fox2
1Center for Brain Circuit Therapeutics, Brigham and Women's Hospital, Boston, Massachusetts; Department of Psychiatry, Harvard Medical School, Boston, Massachusetts.
Biological Psychiatry
|November 18, 2023
Summary
Transcranial magnetic stimulation (TMS) effectiveness depends on targeting specific brain circuits. This review explores identifying and implementing TMS targets for various symptoms across different neurological and psychiatric disorders.
Area of Science:
- Neuroscience
- Neurology
- Psychiatry
Background:
- Clinical effects of transcranial magnetic stimulation (TMS) are increasingly recognized as target-dependent.
- Precise targeting of specific brain circuits may enhance clinical outcomes for various symptoms.
Purpose of the Study:
- To present a conceptual framework for identifying, testing, and implementing symptom-specific brain circuit targets for TMS.
- To explore the application of targeted TMS across different symptoms within a single disorder and across different disorders.
Main Methods:
- Review of existing evidence on TMS target specificity.
- Conceptual analysis of brain circuit targeting for symptom-specific effects.
- Discussion of potential applications in major depression and secondary depression.
Main Results:
- Evidence supports that TMS effects are dependent on the targeted brain circuits.
- Different circuits can modulate distinct symptoms, even within the same disorder (e.g., depression, anxiety).
- The same symptom (e.g., depression) can be targeted across different conditions (e.g., stroke, Parkinson's disease).
Conclusions:
- Symptom-specific targeting of brain circuits is a promising strategy to optimize TMS clinical outcomes.
- This approach allows for tailored interventions for diverse patient populations and symptom profiles.
- Further research is needed to refine the identification and implementation of these targeted TMS protocols.

